Head to Head Review: BioLargo (NASDAQ:BLGO) vs. Koninklijke DSM (OTCMKTS:RDSMY)

Koninklijke DSM (OTCMKTS:RDSMY) and BioLargo (NASDAQ:BLGO) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.

Institutional & Insider Ownership

0.2% of Koninklijke DSM shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Koninklijke DSM and BioLargo, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke DSM	0	0	0	0	N/A
BioLargo	0	0	0	0	N/A

Earnings and Valuation

This table compares Koninklijke DSM and BioLargo”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke DSM	$10.89 billion	2.17	$1.98 billion	N/A	N/A
BioLargo	$12.23 million	5.69	-$3.50 million	($0.03)	-7.81

Koninklijke DSM has higher revenue and earnings than BioLargo.

Profitability

This table compares Koninklijke DSM and BioLargo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Koninklijke DSM	N/A	N/A	N/A
BioLargo	-16.53%	-58.35%	-32.12%

Volatility and Risk

Koninklijke DSM has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, BioLargo has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500.

Summary

Koninklijke DSM beats BioLargo on 7 of the 9 factors compared between the two stocks.

About Koninklijke DSM

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.